Clinical trial · Observational
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography
NCT00775320CI-TRIAL-00041893terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study closed by institutional review board
Summary
Brief summary (as posted)
The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumor | Brain Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| FLT-PET scan | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Brain tumor FLT-PET
- description
- Those diagnosed with a brain tumor and are to undergo surgery
- interventionNames
- Procedure: FLT-PET scan
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or older * Women must not be pregnant or breast feeding * Histologic or strong radiologic suspicion of high grade malignant glioma or ogliometastatic tumor(s) Exclusion Criteria: * May not have received previous therapy for their malignancy
References
Publications (0)
Data not yet available
No reference posted for this study.